The Advantages of Fosamprenavir; Comparing Saquinavir/ritonavir to Lopinavir/r; Reducing Viral Load to 3 Copies; AZT-d4T Cross Resistance; and Rising HCV Rates

Mike Youle

首页> 外文期刊>HIV Treatment Bulletin >The Advantages of Fosamprenavir; Comparing Saquinavir/ritonavir to Lopinavir/r; Reducing Viral Load to 3 Copies; AZT-d4T Cross Resistance; and Rising HCV Rates

【24h】

The Advantages of Fosamprenavir; Comparing Saquinavir/ritonavir to Lopinavir/r; Reducing Viral Load to 3 Copies; AZT-d4T Cross Resistance; and Rising HCV Rates

机译：Fosamprenavir的优势;比较沙奎那韦/利托那韦和洛匹那韦/ r;将病毒载量减少至<3份; AZT-d4T交叉电阻;和HCV率上升

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《HIV Treatment Bulletin》 |2003年第1期|共3页
作者
Mike Youle;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类获得性免疫缺陷综合征（AIDS艾滋病）;
关键词

相似文献

外文文献
中文文献
专利

1. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen [J] . D. William Cameron1 Stephen Becker2? Martin S. King3 Barbara da Silva3 Cheri Klein3 Debbie Tokimoto3 Cheryl Foit3 Deborah Calhoun3 Barry Bernstein3 and George J. Hanna3 Journal of Antimicrobial Chemotherapy . 2007,第5期

机译：探索性研究比较了lopinavir / ritonavir联合沙奎那韦双重蛋白酶抑制剂方案与lopinavir / ritonavir联合齐多夫定/拉米夫定核苷方案的代谢毒性
2. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. [J] . Cameron DW, Becker S, King MS, The Journal of Antimicrobial Chemotherapy . 2007,第5期

机译：探索性研究比较了洛匹那韦/利托那韦加沙奎那韦双重蛋白酶抑制剂方案与洛匹那韦/利托那韦加齐多夫定/拉米夫定核苷方案的代谢毒性。
3. Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting [J] . MonforteA.D., GianottiN., Cozzi-LepriA., Antiviral therapy . 2014,第3期

机译：洛匹那韦/利托那韦单药治疗在观察环境中病毒载量≤50拷贝/毫升的个体的耐久性
4. Determination of Ritonavir, Saquinavir and Lopinavir in Dried Blood Spots by LC/MS/MS Comparing Different Automated Extraction Approaches [C] . Thomas Lloyd, Ravi Orugunty, Adan Orta, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：LC / MS / MS在干血斑中测定Ritonavir，Saquinavir和Lopinavir的不同自动提取方法
5. Durability of lopinavir/ritonavir dual-therapies in individuals with viral load 50 copies/mL in the observational setting [O] . Nicola Gianotti, Alessandro Cozzi-Lepri, Andrea Antinori, 2014

机译：观察条件下洛匹那韦/利托那韦双重疗法在病毒载量50拷贝/ mL的个体中的持久性
6. Durability of lopinavir/ritonavir dual-therapies in individuals with viral load <50 copies/mL in the observational setting [O] . Gianotti, N, Cozzi-Lepri, A, Antinori, A, 2014

机译：观察条件下洛匹那韦/利托那韦双重疗法在病毒载量<50拷贝/ mL的个体中的持久性

The Advantages of Fosamprenavir; Comparing Saquinavir/ritonavir to Lopinavir/r; Reducing Viral Load to 3 Copies; AZT-d4T Cross Resistance; and Rising HCV Rates

著录项

相似文献

相关主题

期刊订阅